Experimental evidence demonstrates that SIRT1 overexpression in VSMCs mitigates angiotensin II (AngII)-induced hypertension, vascular remodeling, and associated pathological alterations in murine models [46]. This evidence concerns the gene AGT and hypertensive disorder.